#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pituitary-dependent Cushing's syndrome Neuroblastoma Leukocyte adhesion deficiency type I Myelofibrosis Acute promyelocytic leukaemia Ornithine transcarbamoylase deficiency Squamous cell carcinoma of the oral cavity Acute lymphocytic leukaemia Urea cycle disorder Systemic scleroderma Chronic lymphocytic leukaemia recurrent Alveolar rhabdomyosarcoma Autoimmune disorder Autoimmune myositis Subdural haematoma More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Life with Disease Wiskott-Aldrich syndrome – Diagnostics Synovial sarcoma recurrent – Trials in Disease Mastocytosis – Trials in Disease Alveolar rhabdomyosarcoma Chronic granulomatous disease – Basic Information Leukoencephalopathy – Trials in Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Leiomyosarcoma recurrent – Basic Information Hereditary motor and sensory neuropathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amikacin Sulfate Art0380 Mesilate Streptococcus Agalactiae Lixudebart ALENDRONATE SODIUM TRIHYDRATE Follitropin Alfa Ddcart‐Cd19 Dimethyl Fumarate Odevixibat GSKVX000000070250 Ds-2325A Hexaminolevulinate Dermatophagoides Pteronyssinus Tasquinimod Sulfamethizole Rbp030.2 Dinoprostone Io103 Acetate VG801-2 Florbetapir (18F) More therapies…

    Learn about Your Condition

    Head and neck cancer stage IV Meningococcal infection Skin bacterial infection Follicular lymphoma stage II Renal cell carcinoma Astrocytoma malignant Pulmonary venous thrombosis Asymptomatic HIV infection Asthmatic crisis Menopause Postoperative delirium Colonoscopy Neurodermatitis Electrocorticogram Heart disease congenital More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Studying the Safety of Aripiprazole and Risperidone in Children and Adolescents with Autism Spectrum Disorder

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Aripiprazole
    • Risperidone
    Germany The Netherlands

  • Study on the Safety and Effectiveness of Methylprednisolone Sodium Succinate and Sodium Chloride for Patients with Severe Cardiac Inflammation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myocarditis
    Investigated Drugs:
    • Methylprednisolone Sodium Succinate
    • Sodium Chloride
    Austria Belgium Czechia Finland Italy Slovenia +2

  • Study on the Effects of Abacavir and Lamivudine in Patients with Systemic Lupus Erythematosus with Low Disease Activity

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Abacavir
    • Lamivudine
    France

  • Study on the Safety and Effectiveness of IPN10200 and Botulinum Toxin Type A for Adults with Moderate to Severe Upper Facial Lines

    Recruiting

    2 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    • Botulinum Toxin Type A – Haemagglutinin Complex
    France Germany

  • Study on Budesonide for COPD Patients with Different Eosinophil Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Budesonide
    Germany The Netherlands Spain

  • Study on Clioquinol for Reducing Seizures in Patients with Drug-Resistant Epilepsy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • Clioquinol
    Belgium
Previous Page
1 … 529 530 531 532 533 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!